Yu An

1.2k total citations
49 papers, 689 citations indexed

About

Yu An is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology and Surgery. According to data from OpenAlex, Yu An has authored 49 papers receiving a total of 689 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Nephrology and 9 papers in Surgery. Recurrent topics in Yu An's work include Chronic Kidney Disease and Diabetes (5 papers), Liver Disease Diagnosis and Treatment (5 papers) and Folate and B Vitamins Research (5 papers). Yu An is often cited by papers focused on Chronic Kidney Disease and Diabetes (5 papers), Liver Disease Diagnosis and Treatment (5 papers) and Folate and B Vitamins Research (5 papers). Yu An collaborates with scholars based in China, United States and United Kingdom. Yu An's co-authors include Zhihong Liu, Caihong Zeng, Rong Xiao, Yongchun Ge, Hui Zhang, Jia Liu, Feng Xu, Weibo Le, Huimei Chen and Ming Zhou and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Bioresource Technology and Journal of the American Society of Nephrology.

In The Last Decade

Yu An

42 papers receiving 682 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu An China 13 198 157 153 116 84 49 689
Heinz Jürgen Roth Germany 19 433 2.2× 146 0.9× 116 0.8× 154 1.3× 61 0.7× 30 1.2k
Yuwen Zhang China 13 107 0.5× 109 0.7× 150 1.0× 63 0.5× 115 1.4× 32 561
Jubbin Jacob India 16 70 0.4× 82 0.5× 187 1.2× 112 1.0× 105 1.3× 62 680
Akihiro Tsuda Japan 17 329 1.7× 74 0.5× 120 0.8× 120 1.0× 67 0.8× 41 662
Kiwon Kim South Korea 16 142 0.7× 152 1.0× 219 1.4× 48 0.4× 133 1.6× 40 773
Keiji Kono Japan 17 313 1.6× 89 0.6× 56 0.4× 86 0.7× 55 0.7× 66 660
Christoph Reichetzeder Germany 22 198 1.0× 276 1.8× 167 1.1× 94 0.8× 64 0.8× 42 1.1k
Paul Glendenning Australia 20 192 1.0× 135 0.9× 136 0.9× 131 1.1× 60 0.7× 47 1.1k
Ana L. Creo United States 11 58 0.3× 134 0.9× 128 0.8× 119 1.0× 82 1.0× 37 643
Robert Haws United States 15 90 0.5× 331 2.1× 136 0.9× 82 0.7× 51 0.6× 33 785

Countries citing papers authored by Yu An

Since Specialization
Citations

This map shows the geographic impact of Yu An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu An more than expected).

Fields of papers citing papers by Yu An

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu An. The network helps show where Yu An may publish in the future.

Co-authorship network of co-authors of Yu An

This figure shows the co-authorship network connecting the top 25 collaborators of Yu An. A scholar is included among the top collaborators of Yu An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu An. Yu An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Yiyang, Yixiang Sun, Yu An, et al.. (2025). Gain-Dominated Phase Customization Enables the Hybrid Quaternary Encoding of Dissipative Soliton Molecules. ACS Photonics. 12(3). 1601–1608.
2.
Lu, Weizhao, Xuan Wang, Yu An, et al.. (2025). Lecithin Alleviates Memory Deficits and Muscle Attenuation in Chinese Older Adults and SAMP8 Mice. Advanced Science. 12(30). e2405222–e2405222.
4.
Chen, Haisheng, Xiaona Du, Jiaying Shen, et al.. (2024). Enhanced Electro‐Optic Coefficients in Single‐Crystalline BaTiO3 Thin Films Enabled by Domain Alignment. Advanced Optical Materials. 12(15). 8 indexed citations
5.
Liang, Hao, et al.. (2024). Glycyrrhetinic acid alleviates atrial fibrillation by inhibiting the expression of PIM1. Chemical Biology & Drug Design. 103(2).
6.
Zhang, Tingjing, et al.. (2024). Serum urate levels and neurodegenerative outcomes: a prospective cohort study and mendelian randomization analysis of the UK Biobank. Alzheimer s Research & Therapy. 16(1). 106–106. 5 indexed citations
8.
Wang, Jie, Yu An, Jia Liu, et al.. (2023). Impaired sensitivity to thyroid hormones is associated with hyperuricemia in a Chinese euthyroid population. Frontiers in Endocrinology. 14. 1132543–1132543. 12 indexed citations
9.
An, Yu, Mingchen Wang, Jie Lu, et al.. (2023). Salinimicrobium profundisediminis sp. nov., isolated from deep-sea sediment of the Mariana Trench. INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY. 73(4). 1 indexed citations
11.
Wang, Jie, Qi Sun, Yu An, et al.. (2022). The association of remnant cholesterol (RC) and interaction between RC and diabetes on the subsequent risk of hypertension. Frontiers in Endocrinology. 13. 951635–951635. 8 indexed citations
12.
Sun, Honglin, Xiaona Chang, Yu An, et al.. (2022). Adipose Tissue Insulin Resistance Is Positively Associated With Serum Uric Acid Levels and Hyperuricemia in Northern Chinese Adults. Frontiers in Endocrinology. 13. 835154–835154. 25 indexed citations
13.
14.
Liu, Jia, et al.. (2022). Plasma Homocysteine Level Is Independently Associated With Conventional Atherogenic Lipid Profile and Remnant Cholesterol in Adults. Frontiers in Cardiovascular Medicine. 9. 898305–898305. 12 indexed citations
15.
An, Yu & Zhihong Liu. (2021). Air Pollution and Kidney Diseases: PM<sub>2.5</sub> as an Emerging Culprit. Contributions to nephrology. 199. 274–284. 17 indexed citations
16.
An, Yu, Haitao Zhang, & Zhihong Liu. (2019). Individualizing Therapy in Lupus Nephritis. Kidney International Reports. 4(10). 1366–1372. 10 indexed citations
17.
Liu, Jing, Jingsong Shi, Yu An, et al.. (2018). Renoprotection Provided by Dipeptidyl Peptidase-4 Inhibitors in Combination with Angiotensin Receptor Blockers in Patients with Type 2 Diabetic Nephropathy. Chinese Medical Journal. 131(22). 2658–2665. 6 indexed citations
18.
Pan, Yu, Song Jiang, Jingsong Shi, et al.. (2016). Comparing the GFR estimation equations using both creatinine and cystatin c to predict the long-term renal outcome in type 2 diabetic nephropathy patients. Journal of Diabetes and its Complications. 30(8). 1478–1487. 7 indexed citations
19.
An, Yu, Feng Xu, Weibo Le, et al.. (2014). Renal histologic changes and the outcome in patients with diabetic nephropathy. Nephrology Dialysis Transplantation. 30(2). 257–266. 171 indexed citations
20.
An, Yu, et al.. (2013). Genetic Counseling Training in China: A Pilot Program at Fudan University. North American Journal of Medicine and Science. 6(4). 221–221. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026